CAJ | 학술논문

从国家中医临床研究基地（湖北）的建设需要出发，创立中药新药研发平台，服务于肝病等重点病种的医院制剂和新药开发。经过5年建设，初步形成了具有创新力的中药新药研发平台，开发了一些特色中药制剂，促进了重点病种的临床服务能力，产生了较好的经济效益和社会效益。本文就中药新药研发平台建设的成果、经验体会及展望进行探讨。
종국가중의림상연구기지（호북）적건설수요출발，창립중약신약연발평태，복무우간병등중점병충적의원제제화신약개발。경과5년건설，초보형성료구유창신력적중약신약연발평태，개발료일사특색중약제제，촉진료중점병충적림상복무능력，산생료교호적경제효익화사회효익。본문취중약신약연발평태건설적성과、경험체회급전망진행탐토。
From the consideration of the requirement of the state traditional Chinese medicine ( TCM ) clinical research facility (Hubei), this article focused on the establishment of the study and exploitation of TCM plat-form which serves exploitation of the hospital pharmaceuticals and new pharmaceuticals of key diseases such as liver disease . After 5 years of construction , the platform with innovative ability was initially formed; some characteristic pharmaceuticals were exploited, which promoted the clinical service ability of key disease, brought good economic and social influence . This article made a preliminary discussion on the construction achieve-ments , experiences and expectations of this platform .